A detailed history of Proficio Capital Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Proficio Capital Partners LLC holds 1,648 shares of AMGN stock, worth $531,002. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,648
Previous 1,611 2.3%
Holding current value
$531,002
Previous $458,000 12.23%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $9,721 - $11,814
37 Added 2.3%
1,648 $514,000
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $41,137 - $49,657
153 Added 10.49%
1,611 $458,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $32,218 - $36,345
126 Added 9.46%
1,458 $419,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $37,389 - $46,419
171 Added 14.73%
1,332 $357,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $17,784 - $21,029
83 Added 7.7%
1,161 $257,000
Q1 2023

Apr 21, 2023

SELL
$225.79 - $275.2 $58.6 Million - $71.4 Million
-259,599 Reduced 99.59%
1,078 $260,000
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $58.6 Million - $71.4 Million
259,457 Added 21266.97%
260,677 $63 Million
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $20,612 - $26,190
90 Added 7.96%
1,220 $320,000
Q3 2022

Oct 11, 2022

BUY
$224.46 - $253.15 $1,571 - $1,772
7 Added 0.62%
1,130 $257,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $692 - $770
3 Added 0.27%
1,123 $273,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $94,286 - $104,305
-430 Reduced 27.74%
1,120 $271,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $22,075 - $25,263
111 Added 7.71%
1,550 $349,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $35,661 - $41,781
-168 Reduced 10.45%
1,439 $306,000
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $3,036 - $3,368
13 Added 0.82%
1,607 $392,000
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $1,553 - $1,810
7 Added 0.44%
1,594 $397,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $47,387 - $56,429
-219 Reduced 12.13%
1,587 $365,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $21,587 - $24,007
92 Added 5.37%
1,806 $440,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $60,529 - $74,278
306 Added 21.73%
1,714 $404,000
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $88,386 - $117,224
485 Added 52.55%
1,408 $301,000
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $174,640 - $224,473
923 New
923 $223,000
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $137,721 - $165,018
-791 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $33,006 - $38,691
-198 Reduced 20.02%
791 $146,000
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $81,391 - $91,746
450 Added 83.49%
989 $188,000
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $892 - $1,041
-5 Reduced 0.92%
539 $105,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $5,558 - $6,266
-30 Reduced 5.23%
544 $113,000
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $664 - $746
-4 Reduced 0.69%
574 $106,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $7,454 - $8,712
44 Added 8.24%
578 $99,000
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $12,321 - $13,767
-73 Reduced 12.03%
534 $93,000
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $101,545 - $115,937
607
607 $113,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.